🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study is to determine if intervening with combined local the...
Status
Completed
Location
Fudan Universtiy Shanghai Cancer Center
Start Date
2019-02-01
Trial ID
NCT03904927
Treatments Being Tested
This study will compare how safe and effective sacituzumab tirumotecan is v...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0119)
Start Date
2024-05-03
Trial ID
NCT06356311
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
This is a dose escalation safety study of birinapant (TL32711) in combinati...
Status
Completed
Location
Holy Cross Hospital
Start Date
2010-10
Trial ID
NCT01188499
Treatments Being Tested
This study is designed to assess the efficacy and safety of QLC5508 in pati...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2026-04-20
Trial ID
NCT07463573
In this study, participants with advanced or metastatic adenocarcinoma or s...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-01
Trial ID
NCT02564263
Treatments Being Tested
This is a multicenter, randomized, open-label, controlled phase III clinica...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-31
Trial ID
NCT07621601
Treatments Being Tested
This pilot feasibility study aims to set the foundation to investigate the ...
Status
Recruiting
Location
National University Hospital
Start Date
2023-02-13
Trial ID
NCT05381038
Treatments Being Tested
This phase III trial compares the effectiveness of pembrolizumab and sacitu...
Status
Recruiting
Location
Cancer Center at Saint Joseph's
Start Date
2025-12-02
Trial ID
NCT06524544
To determine if the regorafenib and nivolumab combination (RegoNivo) improv...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2021-05-05
Trial ID
NCT04879368
Treatments Being Tested